| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating expenses | ||||||
Research and development | ||||||
35,349 | 34,319 | 38,316 | 35,825 | 0 | 0 | 0 |
General and administrative | ||||||
11,306 | 9,952 | 8,262 | 6,701 | 0 | 0 | 0 |
Total operating expenses | ||||||
46,655 | 44,271 | 46,578 | 42,526 | 0 | 0 | 0 |
Loss from operations | ||||||
-46,655 | -44,271 | -46,578 | -42,526 | 0 | 0 | 0 |
Interest income and other income (expense), net | ||||||
0 | - | - | - | 0 | - | - |
Interest income | ||||||
- | - | 0 | 0 | - | 0 | 0 |
Other income (expense), net | ||||||
- | - | - | 0 | - | 0 | 0 |
Net loss | ||||||
-44,449 | -41,975 | -44,246 | -40,272 | 0 | 0 | 0 |
Change in unrealized (losses) gains on marketable securities | ||||||
-8 | 96 | 125 | 78 | 0 | 0 | 0 |
Comprehensive loss | ||||||
-44,457 | -41,879 | -44,121 | -40,194 | 0 | 0 | 0 |
Net loss per common share, basic and diluted | ||||||
-0.59 | 7.17 | -0.54 | -1.30 | -8.69 | -13.06 | -7.47 |
Weighted average number of common shares outstanding used in computing net loss per share, basic and diluted | ||||||
20,250 | 20,510 | 20,158 | 8,218 | 1,101 | 999 | 936 |